Francesco Dionisi, Lamberto Widesott, Marco Van Vulpen, Clifton David Fuller, Rocco Frondizi, Marco Meneguzzo, Pierre Blanchard, Maurizio Amichetti, Giuseppe Sanguineti
{"title":"提高头颈部肿瘤实际质子治疗证据水平的方法。","authors":"Francesco Dionisi, Lamberto Widesott, Marco Van Vulpen, Clifton David Fuller, Rocco Frondizi, Marco Meneguzzo, Pierre Blanchard, Maurizio Amichetti, Giuseppe Sanguineti","doi":"10.14338/IJPT-20-00051.1","DOIUrl":null,"url":null,"abstract":"<p><p>This review aims to present and assess available and new methodologies to increase the clinical evidence of proton therapy data for patients with head and neck cancer. Despite the increasing number of scientific reports showing the feasibility and effectiveness of proton therapy in head and neck cancer, clinical evidence on the potential benefits of its use remains low for several reasons. In this article, the pros and cons of consolidated and new methodologies in this setting such as randomized clinical trials, the model-based approach, and the use of prospective multicentric registries will be detailed.</p>","PeriodicalId":36923,"journal":{"name":"International Journal of Particle Therapy","volume":" ","pages":"328-338"},"PeriodicalIF":2.1000,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270108/pdf/","citationCount":"0","resultStr":"{\"title\":\"Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors.\",\"authors\":\"Francesco Dionisi, Lamberto Widesott, Marco Van Vulpen, Clifton David Fuller, Rocco Frondizi, Marco Meneguzzo, Pierre Blanchard, Maurizio Amichetti, Giuseppe Sanguineti\",\"doi\":\"10.14338/IJPT-20-00051.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This review aims to present and assess available and new methodologies to increase the clinical evidence of proton therapy data for patients with head and neck cancer. Despite the increasing number of scientific reports showing the feasibility and effectiveness of proton therapy in head and neck cancer, clinical evidence on the potential benefits of its use remains low for several reasons. In this article, the pros and cons of consolidated and new methodologies in this setting such as randomized clinical trials, the model-based approach, and the use of prospective multicentric registries will be detailed.</p>\",\"PeriodicalId\":36923,\"journal\":{\"name\":\"International Journal of Particle Therapy\",\"volume\":\" \",\"pages\":\"328-338\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2021-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270108/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Particle Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14338/IJPT-20-00051.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Particle Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14338/IJPT-20-00051.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors.
This review aims to present and assess available and new methodologies to increase the clinical evidence of proton therapy data for patients with head and neck cancer. Despite the increasing number of scientific reports showing the feasibility and effectiveness of proton therapy in head and neck cancer, clinical evidence on the potential benefits of its use remains low for several reasons. In this article, the pros and cons of consolidated and new methodologies in this setting such as randomized clinical trials, the model-based approach, and the use of prospective multicentric registries will be detailed.